According to Statistics Argentina, as of 2022, revenue generated by the Argentina over the counter (OTC) drugs market was USD121.4 through skin treatment and USD90.05 through digestive and intestinal remedies, which caters to the highest count in Argentina.
OTC drugs are also used to manage chronic conditions such as arthritis, diabetes, and high blood pressure. As the population in Argentina ages, the demand for OTC drugs to manage these conditions is expected to grow. OTC drugs are also used to manage lifestyle-related conditions such as insomnia, anxiety, and obesity.
Increasing E-Pharmacy and New Digital Shopper Drives the Market Growth
Inclination Of Companies Toward Over the Counter (OTC) Drugs
The manufacturing cost of OTC drugs in Argentina can vary widely depending on the complexity of the product and the size of the production run. Some estimates suggest that the total manufacturing cost of an OTC drug can range from $2 million to $20 million.
Nearly 9 out of every 10 Latin Americans use OTC medications regularly—that is more than 260 million population prefer OTC medication.
Advertisements And Promotions Promise Market Growth
In 2019, the top 10 OTC drug companies in Argentina spent a total of $68 million on advertisements and promotions, up from $52 million in 2014.
According to a survey conducted by Kantar IBOPE Media, TV is the most effective advertising medium for promoting OTC drugs in Argentina, with 79% of consumers stating that TV ads influence their purchasing decisions.
Growth of
Argentina is using promotional activities such as price discounts, bundling offers, and loyalty programs to drive sales. In 2019, promotions accounted for 10% of the total sales for OTC drugs in Argentina
Download Free Sample Report
Recent Developments
In 2019, Laboratorios Bagó acquired the Argentine OTC drug company, Ibupirac. This acquisition allowed Laboratorios Bagó to expand its product portfolio in the analgesics and anti-inflammatory categories.
In 2020, Laboratorio Elea Phoenix acquired the Argentine OTC drug company, Prodinvest. This acquisition allowed Laboratorio Elea Phoenix to expand its product portfolio in the dermatology and OTC categories.
In 2021, the Argentine pharmaceutical company, Richmond, announced that it had signed an agreement with the Russian Direct Investment Fund (RDIF) to produce the Sputnik V vaccine in Argentina. This development will not only boost the company's production capabilities but also position it as a major player in the global vaccine market.
Market Segmentation
The Argentina over the counter (OTC) drugs market can be segmented by product type, route of administration, dosage form, distribution channel, and region. Based on product type, the market can be segmented into cough, cold, and flu; vitamins, mineral, and supplements (VMS); analgesics; gastrointestinal products; dermatology products; and others. Based on route of administration, the market can be segmented into oral, topical, and parenteral. Based on dosage form, the market can be segmented into tablets, capsules, liquids & solution, creams/lotions/ointments, and others. Based on distribution channel, the market can be grouped into retail pharmacy, hospital pharmacy, and e-pharmacy.
Market Players
Bayer Argentina S.A., Bristol-Myers Squibb Argentina S.R.L., GlaxoSmithKline Argentina S.A., Laboratorios Bagó S.A., Laboratorios Elea S.A.C.I.F., Laboratorios Roemmers S.A.I.C.F., Laboratorios Sidus S.A., Merck Sharp & Dohme Argentina S.A., Novartis Argentina S.A., and Pfizer Argentina S.R.L./Argentina are some of the leading players operating in the Argentina over the counter (OTC) drugs market.
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | Product Type Route of Administration Dosage Form Distribution Channel |
Regional scope | Pampas, Litoral, Northwest, Sierras, and Cuyo |
Key companies profiled | Bayer Argentina S.A., Bristol-Myers Squibb Argentina S.R.L., GlaxoSmithKline Argentina S.A., Laboratorios Bagó S.A., Laboratorios Elea S.A.C.I.F., Laboratorios Roemmers S.A.I.C.F., Laboratorios Sidus S.A., Merck Sharp & Dohme Argentina S.A., Novartis Argentina S.A., Pfizer Argentina S.R.L./Argentina. |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |